MACKENZIE FINANCIAL CORP - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 141 filers reported holding INTERSECT ENT INC in Q3 2017. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q2 2018$1,189,000
-53.6%
31,745
-51.3%
0.00%
-57.1%
Q1 2018$2,562,000
+82.2%
65,200
+50.3%
0.01%
+133.3%
Q4 2017$1,406,000
+7.1%
43,380
+2.9%
0.00%
-57.1%
Q3 2017$1,313,000
+29.1%
42,160
-21.2%
0.01%
-22.2%
Q1 2016$1,017,000
-28.2%
53,508
-15.1%
0.01%0.0%
Q4 2015$1,417,000
+48.5%
62,990
+54.6%
0.01%
+50.0%
Q3 2015$954,000
-30.4%
40,754
-14.8%
0.01%
-14.3%
Q2 2015$1,370,000
+76.3%
47,860
+59.0%
0.01%
+75.0%
Q1 2015$777,00030,0930.00%
Other shareholders
INTERSECT ENT INC shareholders Q3 2017
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders